Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial)

Journal of Hospital Infection

Volumn 96, Issue 3, 2017, Pages 223-228

  Webster, J ^a,b   Larsen, E ^a,b   Marsh, N ^a,b   Choudhury, A ^b,c,d   Harris, P ^a,c   Rickard, C M ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF THE SUNSHINE COAST   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Catheter related infections; Chlorhexidine; Feasibility studies; Polyhexamethylene biguanide; Randomized controlled trial

Indexed keywords

CHLORHEXIDINE GLUCONATE; POLY(HEXAMETHYLENEBIGUANIDE); BIGUANIDE DERIVATIVE; CHLORHEXIDINE; DISINFECTANT AGENT; POLIHEXANIDE;

ADULT; ARTICLE; BIOLOGICAL DRESSING; CATHETER INFECTION; CELLULITIS; CONTROLLED STUDY; DEVICE REMOVAL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; SAFETY; SKIN INFECTION; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; TERTIARY CARE CENTER; WOUND INFECTION; ADOLESCENT; AGED; ANALOGS AND DERIVATIVES; BANDAGE; CENTRAL VENOUS CATHETERIZATION; DISINFECTION; INCIDENCE; MIDDLE AGED; PROCEDURES; SEPSIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BANDAGES; BIGUANIDES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHLORHEXIDINE; DISINFECTANTS; DISINFECTION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEPSIS; TERTIARY CARE CENTERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85019415521     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2017.04.009     Document Type: Article

References (23)

1. Maki, D.G., Kluger, D.M., Crnich, C.J., The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81 (2006), 1159–1171.
2. Barnett, A.G., Page, K., Campbell, M., Martin, E., Rashleigh-Rolls, R., Halton, K., et al. The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case–control study. BMJ Open, 3, 2013, e003587.
3. Halton, K.A., Cook, D., Paterson, D.L., Safdar, N., Graves, N., Cost-effectiveness of a central venous catheter care bundle. PLoS One, 5, 2010 pii: e12815.
4. Sagana, R., Hyzy, R.C., Achieving zero central line-associated bloodstream infection rates in your intensive care unit. Crit Care Clin 29 (2013), 1–9.
5. Mimoz, O., Lucet, J.C., Kerforne, T., Pascal, J., Souweine, B., Goudet, V., et al. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:10008 (2015), 2069–2077.
6. Pronovost, P., Needham, D., Berenholtz, S., Sinopoli, D., Chu, H., Cosgrove, S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 (2006), 2725–2732.
7. Lai, N.M., Chaiyakunapruk, N., Lai, N.A., O'Riordan, E., Pau, W.S., Saint, S., Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev, 6, 2013, CD007878.
8. O'Horo, J.C., Silva, G.L., Safdar, N., Anti-infective locks for treatment of central line-associated bloodstream infection: a systematic review and meta-analysis. Am J Nephrol 34 (2011), 415–422.
9. Bhende, S., Rothenburger, S., In vitro antimicrobial effectiveness of 5 catheter insertion-site dressings. J Assoc Vasc Access 12 (2007), 227–231.
10. Safdar, N., O'Horo, J.C., Ghufran, A., Bearden, A., Didier, M.E., Chateau, D., et al. Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis. Crit Care Med 42 (2014), 1703–1713.
11. Wall, J.B., Divito, S.J., Talbot, S.G., Chlorhexidine gluconate-impregnated central-line dressings and necrosis in complicated skin disorder patients. J Crit Care, 29, 2014, 1130 e1–4.
12. Lenselink, E., Andriessen, A., A cohort study on the efficacy of a polyhexanide-containing biocellulose dressing in the treatment of biofilms in wounds. J Wound Care 20:534 (2011), 6–9.
13. Sibbald, R.G., Coutts, P., Woo, K.Y., Reduction of bacterial burden and pain in chronic wounds using a new polyhexamethylene biguanide antimicrobial foam dressing – clinical trial results. Adv Skin Wound Care 24 (2011), 78–84.
14. Dilamian, M., Montazer, M., Masoumi, J., Antimicrobial electrospun membranes of chitosan/poly (ethylene oxide) incorporating poly (hexamethylene biguanide) hydrochloride. Carbohydr Polym 94 (2013), 364–371.
15. Schulz, K.F., Altman, D.G., Moher, D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 9 (2010), 672–677.
16. Centers for Disease Control and Prevention. Surveillance for bloodstream infections. Central line-associated bloodstream infection (CLABSI) and non-central line-associated bloodstream infection. Available at: http://www.cdc.gov/nhsn/acute-care-hospital/clabsi/ [last accessed March 2015].
17. Hooper R. Justifying sample size for a feasibility study. Research Design Service. National Institute for Health Research London. Available at: http://www.rds-london.nihr.ac.uk/RDSLondon/media/RDSContent/files/PDFs/Justifying-Sample-Size-for-a-Feasibility-Study_1.pdf [last accessed March 2015].
18. O'Neil, C., Ball, K., Wood, H., McMullen, K., Kremer, P., Jafarzadeh, S.R., et al. A central line care maintenance bundle for the prevention of central line-associated bloodstream infection in non-intensive care unit settings. Infect Control Hosp Epidemiol 37 (2016), 692–698.
19. Erdei, C., McAvoy, L.L., Gupta, M., Pereira, S., McGowan, E.C., Is zero central line-associated bloodstream infection rate sustainable? A 5-year perspective. Pediatrics 135 (2015), e1485–e1493.
20. Zingg, W., Cartier, V., Inan, C., Touveneau, S., Theriault, M., Gayet-Ageron, A., et al. Hospital-wide multidisciplinary, multimodal intervention programme to reduce central venous catheter-associated bloodstream infection. PLoS One, 9, 2014, e93898.
21. Timsit, J.F., Mimoz, O., Mourvillier, B., Souweine, B., Garrouste-Orgeas, M., Alfandari, S., et al. Randomised controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 186 (2012), 1272–1278.
22. Lai, N.M., Taylor, J.E., Tan, K., Choo, Y.M., Ahmad Kamar, A., Muhamad, N.A., Antimicrobial dressings for the prevention of catheter-related infections in newborn infants with central venous catheters. Cochrane Database Syst Rev(3), 2016, CD011082.
23. Marschall, J., Mermel, L.A., Classen, D., Arias, K.M., Podgorny, K., Anderson, D.J., et al. Strategies to prevent central line associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 29:Suppl 1 (2008), S22–S30 (Erratum in: Infect Control Hosp Epidemiol 2009;30:815).